Aurora Cannabis (TSX:ACB) Surged 135% in 1 Week: Are Pot Stocks Back?

Last week, Aurora Cannabis Inc (TSX:ACB) surged 135%. What explains this totally unexpected rally?

| More on:
Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Last week, Aurora Cannabis (TSX:ACB)(NYSE:ACB) shares soared 135% in a single week, breaking a months-long downtrend. The rally occurred around the same time that the company announced it expected $64 million in sales in Q1. Aurora’s quarterly report for Q1 fiscal 2021 isn’t finalized, but people are still expecting the company to deliver solid results. If it does, then perhaps last week’s rally will continue into this week.

What explains the rally?

There are two theories widely circulating to explain Aurora’s massive rally last week:

  1. Upcoming earnings.
  2. Short-sellers covering their sales.

The first theory merits some explanation. Aurora is expecting to deliver $64 million in sales in Q1, which is down from $70 million in the same quarter a year ago and $72 million in the previous quarter. The expected sales decline looks bad on the surface. However, Aurora has spent much of 2020 spinning off business units, in a bid to strengthen its balance sheet. In this context, the lower revenue could be a positive. If Aurora’s revenue only declines slightly after it sells off unprofitable assets, then that may improve overall profitability. That would be an unambiguously positive development.

There’s also the theory that Aurora rallied due to short-sellers covering their positions. This theory was advanced by Keith Speights of Fool.com. When short-sellers buy back shares to cover their positions, that results in a short-lived rally. According to Speights, up to 19% of ACB shares were being sold short as of October 15. If that’s the case, then those short-sellers may have covered their positions later, leading to an illusory rally.

ACB is still losing money

Despite the optimism some feel toward Aurora Cannabis, the company still losing money. A lot of it. In fiscal 2020, the company had a staggering $3.3 billion net loss. That was partially due to non-cash factors like impairment, but even if you look at cash flow, the situation wasn’t good. ACB lost $337 million in cash from operations and also had net outflows from financing and investing activities.

The company’s upcoming quarterly report is going to be interesting in light of this. The reason why $64 million in revenue is being described as a positive is because it comes after several asset spinoffs. If Aurora can still bring in $64 million in sales after selling its underperforming businesses, then maybe it has a future ahead of it after all.

We’ll just have to wait and see. Aurora has had profitable quarters before, and there’s no reason it couldn’t have more ahead of it. But just like 2020’s massive losses were due to non-recurring factors, so were its previous profitable quarters. The company has generally lost money in terms of cash flow. So, despite last week’s gains, it’s far from certain that this company can turn its situation around.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »